Thierry Huet

Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland.

The Institut Pasteur is a private non-profit foundation which contributes to the prevention and treatment of disease, through research, education, and public health activities. The firm was founded in 1887, and is based in Paris.

Part of Ernst & Young Global Ltd., Arthur Andersen /Belgium/ is a Belgian company that provides accounting services. The company is located in Belgium. The company was founded by Stéphane Verdood. Arthur Andersen /Belgium was acquired by Deloitte & Touche LLP from Arthur Andersen LLP on April 18, 2002.

Elaia Partners SAS (Elaia) is an independent French private equity boutique which was founded in 2002. Named after the Greek word for olive tree, the symbol of resilience, longevity and prosperity, Elaia focuses on software technology companies. The firm is headquartered in Paris and manages Elaia Ventures, a French FCPR fund backed by financial institutions, industrial investors and family offices.

Ariana Pharmaceuticals SA provides pharmaceutical, clinical and data technology. It offers analytics for multi-paramedic data in identifying patient responders to reduce clinical and drug development risk. The firm also develops biomarker signatures to develop processes in anawlyzing multi-paramedic data. The company was founded by Mohammad Afshar in 2003 and is headquartered in Paris, France.

HealthCare Medical Technologies, Inc. provides healthcare management services to health plans focused on obesity, diabetes, renal failure, heart disease, and high risk obstetrics. The company is headquartered in Sioux Falls, SD.

Part of Leadership Foundations, The International Women's Forum is a women's forum membership organization. The company is based in Washington. The American company was founded in 1974 by Maureen A. Kindel, Elinor Guggenheimer. Stephanie Mathews O'Keefe has been the CEO of the company since 2016. The International Women's Forum was acquired by Leadership Foundations on January 01, 2021.

Trod Medical NV develops and commercializes tools for use in the focal ablation of soft tissues. The company was founded by Andre Scattolin Faure on June 29, 2006 and is headquartered in Leuven, Belgium.

The International Aviation Womens Association (IAWA) is an international organization that brings together women who hold positions of impact in the aviation and aerospace industry. The private company is based in Edgewater, MD. Through annual conferences, regional receptions, and connects, IAWA provides a forum to share views on matters of importance to the industry, as well as to women in general. IAWA members serve as role models for other women seeking advancement and growth in the industry. Additionally, IAWA encourages young women to enter the aviation and aerospace industries through its scholarship program. Founded in 1988, IAWA promotes the advancement of women of achievement throughout the world.

Biotechnological Enzymatic Catalyse NV develops, produces and commercializes enzymatic systems for food preservation. It engages in the research, development and manufacturing of antimicrobial products for food safety. The firm's solutions are designed for use in the following: dairy products, fruit and vegetable juices, sauces and dressings and liquid egg products. The company was founded in 1992 and is headquartered in Ghent, Belgium.

Vesalius Biocapital Partners SARL (Vesalius Biocapital Partners) is an independent venture capital firm founded in 2007 by Stéphane Verdood. The firm is headquartered in Luxembourg.

Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million.

Apitope International NV develops therapeutic vaccines. It operates as a bio-pharmaceutical company that engages in developing peptide therapies. The firm specializes on the discovery and development of revolutionary disease modifying therapies for treating autoimmune and allergic diseases, including multiple sclerosis, and Graves’ disease, FVIII intolerance and uveitis. The company was founded by David Wraith in 2002 and is headquartered in Diepenbeek, Belgium.

Apitope Technology (Bristol) Ltd. is a European biotech company developing therapeutic vaccines for treating autoimmune and allergic diseases, including multiple sclerosis, Type 1 diabetes, Graves' disease, allergies and organ transplant rejection. The team at Apitope is developing potential therapies intended to selectively treat the underlying cause of a range of autoimmune diseases rather than simply treat the disease symptoms or non-specifically suppress the whole immune system. Apitope's approach is based on well-established scientific evidence published in leading scientific journals showing that soluble, synthetic peptides can selectively suppress abnormal immune responses and reinstate the normal immune balance and thereby, tolerance. The firm's strategy is to position itself as a significant player in the therapeutic peptide space and make it a partner of choice for pharmaceutical companies keen to develop disease modifiers for autoimmune conditions. It has a highly experienced senior management team, with a proven track record in discovering and developing innovative compounds. The company's lead product candidate is under investigation for the potential treatment of multiple sclerosis and is currently in Phase I clinical development. It is partnered with Merck-Serono (a division of Merck KGaA, Darmstadt, Germany), one of the leading companies in the development and marketing of MS therapies.

Institut Français Des Administrateurs is a private company based in Paris, France. The French company promotes governance and develops leadership skills.

Applied Biosystems France SA provides medical products. The company is headquartered in Courtaboeuf, France.

Airbus France SAS manufactures & suppliers commercial aircraft. It also provides services related to Aircraft Builders. Airbus has become one of the two largest suppliers of commercial aircraft with a capacity of more than 100 seats and has delivered over 3,000 machines. The company was founded in 1970 and is headquartered in Toulouse, France.

ETHERA SA provides diagnostic kits for indoor air pollution. It also develops solutions for measurement of chemical pollutants in the indoor air, especially for toxic volatile organic compounds. The firm's products include Profil'air modules, Profil'air sensors and Profil'air accessories. The company was founded by Yves Bigay, Thu-Hoa Tran-Thi and Sylvain Colomb in 2010 and is headquartered in Crolles, France.

Value For Growth NV provides independent consulting and coaching services. The private company is based in Tervuren, Belgium. The Belgian company was founded by Gaston Mattyssens, Stéphane Verdood.

Fast Forward Pharmaceuticals BV develops novel disease-modifying therapeutics for the treatment of inflammatory and autoimmune diseases. It is developing an anti-CD40 monoclonal antibody therapy for the treatment of chronic inflammatory diseases like primary biliary cirrhosis and Crohn’s disease. The company was founded by Louis Boon in October 2010 and is headquartered in Utrecht, Netherlands.

Fabentech SAS developes immunotherapeutic solutions for emerging infectious diseases as well as for certain drug intoxications. Its products include infography development, Lassa(FBH-003) and other emerging diseases. The company was founded by Bertrand Lepine on June 5, 2009 and is headquartered in Lyon, France.

SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France.

Nosopharm SAS operates as a biotechnology company. It develops an anti-infective drug platform that is based on the medicinal chemistry of a novel antibiotic class used to cure life-threatening multi-resistant hospital-acquired infections. The company was founded by Philippe Villain-Guillot and Maxime Gualtieri in February 2009 and is headquartered in Nimes, France.

Founded in 2008, Standard BioTools UK Ltd. is a subsidiary of Standard BioTools, Inc. that sells microfluidic and mass cytometer systems. The company is based in London, UK.

Part of Standard BioTools, Inc., Standard BioTools France SARL is a French company that provides advertising services. The company is based in Les Ulis, France.

Standard BioTools Europe BV creates and manufactures technologies and life science tools designed to revolutionize biology through a relentless pursuit of scientific truth. Its core technologies, based on microfluidics and mass cytometry, enable the exploration and analysis of individual cells as well as the industrial application of genomics. The company was founded in 1999 and is headquartered in Amsterdam, Netherlands.